Division of Cardiovascular Medicine Archives
Study shows CMS reimbursement not associated with wider EPD use
Sep. 29, 2022—Vanderbilt research shows that higher reimbursement from the Centers for Medicare & Medicaid Services was not associated with wider use of an embolic protection device during transcatheter aortic valve replacement procedures.
Study suggests new mechanism for lipid transporter
Sep. 15, 2022—A new model suggests that a protein involved in the generation of high-density lipoprotein (HDL) works differently than previously thought.
Lindley named to direct new multidisciplinary Women’s Heart Center
Aug. 17, 2022—Kathryn Lindley, MD, has joined the Vanderbilt Heart and Vascular Institute as director of the new Women’s Heart Center.
Genotype-specific blood counts
Aug. 11, 2022—Vanderbilt researchers report genotype-specific reference ranges to improve interpretation of laboratory blood results in African Americans with a common gene variant that lowers white blood cell counts.
Peptides promote AFib arrhythmia
Apr. 11, 2022—Peptide oligomers have detrimental metabolic effects and cause pro-arrhythmic electrophysiological changes in heart atria, suggesting they may contribute to atrial fibrillation.
Department of Medicine announces $1 million endowment to support diversity, inclusion efforts
Mar. 14, 2022—Vanderbilt University Medical Center’s Department of Medicine has announced a $1 million endowment dedicated to the department’s efforts in diversity and inclusion.
American College of Cardiology honors Vanderbilt’s Dixon, Thomas
Mar. 10, 2022—Two fellows in Vanderbilt's Division of Cardiovascular Medicine have received awards from the American College of Cardiology and the Association of Black Cardiologists.
Chest Pain Center receives reaccreditation from ACC
Mar. 3, 2022—Vanderbilt University Medical Center has been reaccredited as a Chest Pain Center with Primary Percutaneous Coronary Intervention (PCI) and Resuscitation.
Study finds genetic testing useful for young AFib patients
Oct. 7, 2021—Vanderbilt research shows that genetic testing in patients with early-onset atrial fibrillation can identify variants associated with more serious cardiomyopathy and arrhythmia syndromes that may otherwise remain undiagnosed.
Stevenson receives HFSA Lifetime Achievement Award
Sep. 23, 2021—Vanderbilt's Lynne Warner Stevenson, MD, has received the Lifetime Achievement Award from the Heart Failure Society of America.
New Clinician Spotlight: Jane Freedman
Sep. 8, 2021—Jane Freedman, MD, has joined Vanderbilt University Medical Center as director of the Division of Cardiovascular Medicine and physician-in-chief of the Vanderbilt Heart and Vascular Institute.
Regulators of fat cell metabolism
Sep. 7, 2021—Vanderbilt researchers have discovered new details of the regulation of fat cell metabolism, findings that are important for combating obesity.
